Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 30, 2010

Primary Completion Date

November 1, 2022

Study Completion Date

December 1, 2022

Conditions
Prostate Cancer
Trial Locations (8)

Unknown

Hôpital de Gatineau, Gatineau

CHUM-Notre- Dame, Montreal

Hôpital Maisonneuve-Rosemont, Montreal

Jewish General Hospital, Montreal

Montreal General Hospital, Montreal

CHUQ, L'Hôtel-Dieu de Québec, Québec

CHUS - Hôpital Fleurimont - Sherbrooke, Sherbrooke

Centre Hospitalier régional de Trois-Rivières, Trois-Rivières

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Dr. Tamim Niazi

OTHER